RSI Overbought Stocks
BFLY is RSI overbought, meaning strong buying pressure may lead to a short-term consolidation or pullback.
NYSE:BFLY • US1241551027
The current stock price of BFLY is 5.425 USD. Today BFLY is up by 11.63%. In the past month the price increased by 13.82%. In the past year, price increased by 107.69%.
BFLY currently appears in the following ChartMill screener lists.
ChartMill assigns a technical rating of 9 / 10 to BFLY. When comparing the yearly performance of all stocks, BFLY is one of the better performing stocks in the market, outperforming 91.6% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to BFLY. BFLY has a great financial health rating, but its profitability evaluates not so good.
On February 26, 2026 BFLY reported an EPS of -0.06 and a revenue of 31.51M. The company beat EPS expectations (7.12% surprise) and beat revenue expectations (19.19% surprise).
11 analysts have analysed BFLY and the average price target is 5.67 USD. This implies a price increase of 4.59% is expected in the next year compared to the current price of 5.425.
For the next year, analysts expect an EPS growth of 22.13% and a revenue growth 29.23% for BFLY
Over the last trailing twelve months BFLY reported a non-GAAP Earnings per Share(EPS) of -0.31. The EPS increased by 6.06% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -26.03% | ||
| ROE | -39.38% | ||
| Debt/Equity | 0 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 16.63 | 176.478B | ||
| ISRG | INTUITIVE SURGICAL INC | 44.49 | 166.347B | ||
| SYK | STRYKER CORP | 22.32 | 130.688B | ||
| BSX | BOSTON SCIENTIFIC CORP | 18.29 | 96.022B | ||
| IDXX | IDEXX LABORATORIES INC | 38.75 | 46.124B | ||
| EW | EDWARDS LIFESCIENCES CORP | 25.78 | 45.085B | ||
| BDX | BECTON DICKINSON AND CO | 11.35 | 44.283B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 14.14 | 33.542B | ||
| RMD | RESMED INC | 18.46 | 33.332B | ||
| DXCM | DEXCOM INC | 24.15 | 23.684B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.1 | 18.234B | ||
| HOLX | HOLOGIC INC | 15.48 | 16.969B | ||
| PODD | INSULET CORP | 31.14 | 14.256B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. The company is headquartered in Burlington, Massachusetts and currently employs 220 full-time employees. The company went IPO on 2020-05-26. The firm's solution, leveraging its Ultrasound-on-Chip technology, enables the practical application of ultrasound information into the clinical workflow. Its product portfolio includes a combination of hardware and software, including Butterfly iQ3, Butterfly iQ+, Butterfly iQ+ Bladder, and Butterfly iQ+ Vet devices, software subscriptions, and professional services. The company offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials as well as its ScanLab education-only app, formal education programs through its Butterfly Academy software and Butterfly Certified courses, as well as professional services for large scale deployments. Its devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, and Australia.
IPO: 2020-05-26
BUTTERFLY NETWORK INC
1600 District Avenue
Burlington MASSACHUSETTS 06437 US
CEO: Todd Fruchterman
Employees: 220
Phone: 17815574800
Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. The company is headquartered in Burlington, Massachusetts and currently employs 220 full-time employees. The company went IPO on 2020-05-26. The firm's solution, leveraging its Ultrasound-on-Chip technology, enables the practical application of ultrasound information into the clinical workflow. Its product portfolio includes a combination of hardware and software, including Butterfly iQ3, Butterfly iQ+, Butterfly iQ+ Bladder, and Butterfly iQ+ Vet devices, software subscriptions, and professional services. The company offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials as well as its ScanLab education-only app, formal education programs through its Butterfly Academy software and Butterfly Certified courses, as well as professional services for large scale deployments. Its devices are commercially available to trained healthcare practitioners in areas including, but not limited to, parts of Africa, Asia, and Australia.
The current stock price of BFLY is 5.425 USD. The price increased by 11.63% in the last trading session.
BFLY does not pay a dividend.
BFLY has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
11 analysts have analysed BFLY and the average price target is 5.67 USD. This implies a price increase of 4.59% is expected in the next year compared to the current price of 5.425.
BUTTERFLY NETWORK INC (BFLY) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.31).
BUTTERFLY NETWORK INC (BFLY) has a market capitalization of 1.38B USD. This makes BFLY a Small Cap stock.